We are live on ! Find out more
MSKCC

Memorial Sloan Kettering Cancer Center Portfolio holdings

AUM $24.6M
1-Year Est. Return 10.16%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+10.16%
3 Year Est. Return
-14.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$86.4M
AUM Growth
-$72.8M
Cap. Flow
-$64.5M
Cap. Flow %
-74.73%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$61M
2
ILMN icon
Illumina
ILMN
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 67.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
1
Royalty Pharma
RPRX
$25.8B
$44M 50.9%
1,128,255
-1,552,389
-58% -$61M
GDX icon
2
VanEck Gold Miners ETF
GDX
$27.6B
$28.3M 32.79%
738,500
– –
CRBU icon
3
Caribou Biosciences
CRBU
$165M
$6.19M 7.17%
674,196
– –
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.41B
$3.22M 3.72%
602,272
– –
ILMN icon
5
Illumina
ILMN
$29B
$2.41M 2.79%
7,080
-10,597
-60% -$3.58M
YMAB
6
DELISTED
Y-mAbs Therapeutics
YMAB
$2.27M 2.63%
191,176
– –

Similar funds

BRC
Bishop Rock Capital New York $24.3M AUM 20.73% 1-Year Est. Return
NAM
Nationwide Asset Management Columbus, Ohio $25.1M AUM 13.37% 1-Year Est. Return
TAAM
Top Ace Asset Management Hong Kong $25.3M AUM 23.27% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
AG
Appleton Group Appleton, Wisconsin $28.6M AUM 32.21% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Memorial Sloan Kettering Cancer Center's Q1 2022 Portfolio in Review

As of Q1 2022, Memorial Sloan Kettering Cancer Center held 6 positions worth $86.4M, down 46% from $159M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Memorial Sloan Kettering Cancer Center withdrew a net $64.5M in Q1 2022, reducing 2 holdings. Its largest reduction was Royalty Pharma, cutting an estimated $61M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, down from 85% a quarter earlier.

  • Memorial Sloan Kettering Cancer Center's biggest Q1 2022 reduction was Royalty Pharma, cutting an estimated $61M.
  • Memorial Sloan Kettering Cancer Center's ten largest holdings make up 100% of its $86.4M portfolio in Q1 2022.
  • Memorial Sloan Kettering Cancer Center opened 0 new positions and closed 0 in Q1 2022.
  • Memorial Sloan Kettering Cancer Center's portfolio value fell 46% quarter-over-quarter to $86.4M.

Based on Memorial Sloan Kettering Cancer Center's 13F filing for Q1 2022, filed 16 May 2022.